Research output per year
Research output per year
Fingerprint
Dive into the research topics where Shiwen Peng is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 12 Similar Profiles
Network
Recent external collaboration on country level. Dive into details by clicking on the dots.
Research output
-
Development of dna vaccine targeting e6 and e7 proteins of human papillomavirus 16 (Hpv16) and hpv18 for immunotherapy in combination with recombinant vaccinia boost and pd-1 antibody
Peng, S., Ferrall, L., Gaillard, S., Wang, C., Chi, W. Y., Huang, C. H., Roden, R. B. S., Wu, T. C., Chang, Y. N. & Hung, C. F., Jan 1 2021, In: mBio. 12, 1, p. 1-19 19 p., e03224-20.Research output: Contribution to journal › Article › peer-review
Open Access -
PD-1 blockade synergizes with intratumoral vaccination of a therapeutic HPV protein vaccine and elicits regression of tumor in a preclinical model
Peng, S., Tan, M., Li, Y. D., Cheng, M. A., Farmer, E., Ferrall, L., Gaillard, S., Roden, R. B. S., Hung, C. F. & Wu, T. C., Apr 2021, In: Cancer Immunology, Immunotherapy. 70, 4, p. 1049-1062 14 p.Research output: Contribution to journal › Article › peer-review
-
Structure-function analyses of candidate small molecule RPN13 inhibitors with antitumor properties
Anchoori, R. K., Tan, M., Tseng, S. H., Peng, S., Soong, R. S., Algethami, A., Foran, P., Das, S., Wang, C., Wang, T. L., Liang, H., Hung, C. F. & Roden, R. B. S., Jan 1 2020, In: PloS one. 15, 1, e0227727.Research output: Contribution to journal › Article › peer-review
Open Access -
Covalent Rpn13-Binding Inhibitors for the Treatment of Ovarian Cancer
Anchoori, R. K., Jiang, R., Peng, S., Soong, R. S., Algethami, A., Rudek, M. A., Anders, N., Hung, C. F., Chen, X., Lu, X., Kayode, O., Dyba, M., Walters, K. J. & Roden, R. B. S., Sep 30 2018, In: ACS Omega. 3, 9, p. 11917-11929 13 p.Research output: Contribution to journal › Article › peer-review
-
Epithelial boost enhances antigen expression by vaccinia virus for the generation of potent CD8+ T cell-mediated antitumor immunity following DNA priming vaccination
Qiu, J., Peng, S., Ma, Y., Yang, A., Farmer, E., Cheng, M. A., Roden, R. B. S., Wu, T. C., Chang, Y. N. & Hung, C. F., Dec 2018, In: Virology. 525, p. 205-215 11 p.Research output: Contribution to journal › Article › peer-review